Pediatric tonsillopharyngitis - An evaluation of cefprozil in Indian patients

Indian Journal of Pediatrics

Volumn 71, Issue 7, 2004, Pages 601-605

  Gupta, Nomeeta ^a   Mukherjee, Abhijit ^a   Moharana, A K ^b,c  

^a Batra Hospital India   (India)

^b RANBAXY LABORATORIES LTD   (India)

^c NONE   (India)

Author keywords

Cefprozil; Penicillin; Pharyngitis; Streptococcal tonsillopharyngitis

Indexed keywords

CEFACLOR; CEFPROZIL;

ABDOMINAL DISCOMFORT; ARTICLE; BACTERIAL INFECTION; CHILD; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; ERADICATION THERAPY; EVALUATION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT COMPLIANCE; PENICILLIN RESISTANCE; PHARYNGITIS; SIDE EFFECT; STREPTOCOCCUS INFECTION; TONSILLITIS; TONSILLOPHARYNGITIS; VOMITING;

EID: 4043158443     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02724119     Document Type: Article

References (18)

1. Milatovic D, Adam D, Hamilton H, Materman E. Cefprozil versus penicillin V in the treatment of streptococcal tonsillopharyngitis. Antimicrob Agents Chemother 1993; 37: 1620-1623.
2. Sinkinson CA, Pichichero ME, Centor RM. The compromises of managing acute pharyngitis. Emerg Med 1988; 9: 161-68.
3. Gastanaduy AS, Kaplan EL, Huwe BB et al. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet 1980; 11: 498-501.
4. Brook L. The role of β lactamase producing bacteria in the persistence of streptococcal bacterial infection. Rev Infect Dis 1984; 6: 601-607.
5. Wiseman LR, Benfield P. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 1993; 45(2): 295-317.
6. De la Garza CA, Nolen TM, Rogan MP. Cefprozil vs. erythromycin in streptococcal tonsillopharyngitis. Infections in Medicine 1992; 9(Suppl E): 8-20.
7. Barbarash RA, Solomon E, Thieneman Jr. A, Stricker WE, Scott JC et al. Cefprozil versus amoxicillin/clavulanate in mild to moderate lower respiratory tract infections. Infections in Medicine 1992; 9(Suppl E): 40-47.
8. Wilber RB, Hamilton H, Leroy A, Gres J, Durham SJ et al. Cefprozil vs. cefaclor in the treatment of lower respiratory tract infections. Infections in Medicine 1992; 9(Suppl C): 45-46.
9. Solomon E, McCarty JM, Morman MR, Ginsberg D, Nolen TM, et al. Comparison of cefprozil and amoxicillin/clavulanate potassium in the treatment of skin and skin structure infections in adults. Advances in Therapy 1992; 9: 156-165.
10. Iravani A, Doyle CA, Durham SJ, Wilber RB. The Cefprozil Multicentre Study Group. Cefprozil vs. cefaclor in the treatment of acute and uncomplicated urinary tract infections. Clinical Therapeutics 1992; 14: 314-326.
11. Barbhaiya RH, Shukla UA, Gleason CR et al. Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration. Antimicrob Agents Chemother 1990; 34: 1204-1209.
12. R.Brooks GH, Morgantown WV. Cefprozil, A new cephalosporin: Its use in various clinical trials. Southern Medical Journal 1995; 88(3): 338-346.
13. Gerson A. Treatment of upper and lower respiratory tract infections: clinical trials with cefprozil. Pediatr Inf Dis J 1987; 17: S83-88.
14. Ginsburgh CM, McCracken GH, Crow SD, Steinberg JB, Cpoe F. A controlled comparative study of penicillin V and cefadroxil therapy of group A streptococcal tonsillopharyngitis. J Int Med Res 1980; 8(suppl 1): 82-86.
15. Hennes DM. A clinical experience with cefadroxil in upper respiratory tract infection. J Antimicrob Chemother 1982; 10 (Suppl B): 125-35.
16. De La Garza CA, Nolen TM, Rogan MP. Cefprozil vs. cefaclor in streptococcal tonsillopharyngitis. Infect Med 1992; 9(Suppl E): 8-20.
17. Doyle CA, Durham SJ, Hamilton HA, Wilber RB. Cefprozil vs. cefaclor in the treatment of pharyngitis and tonsillitis in adults. Infect Med 1992; 9(Suppl E): 66-7.
18. Sackett DL and Haynes RB, eds. Compliance with Therapeutic Regimens. Baltimore, MD. Johns Hopkins University Press, 1976; 293p.